These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34887139)

  • 21. Loss of contact sensitization evaluated by laser Doppler blood flowmetry and transepidermal water loss measurement.
    Seo KI; Eun HC
    Contact Dermatitis; 1996 Apr; 34(4):233-6. PubMed ID: 8730158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 23. Alopecia areata.
    Perera E; Yip L; Sinclair R
    Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
    Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
    Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore.
    Leong WMS; Mok ZR; Chandran NS
    Dermatol Ther; 2020 Nov; 33(6):e14447. PubMed ID: 33098604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allergic contact dermatitis and systemic contact dermatitis in a patient with polysensitization to topical corticosteroids].
    Gómez-de la Fuente E; Rosado A; Gutiérrez-Pascual M; Vicente FJ; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 Nov; 100(9):817-20. PubMed ID: 19889306
    [No Abstract]   [Full Text] [Related]  

  • 30. Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata.
    Temesvári E; González R; Marschalkó M; Horváth A
    Contact Dermatitis; 2004 Jun; 50(6):381-2. PubMed ID: 15274737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of alopecia areata using the contact allergen diphencyprone.
    Hull SM; Cunliffe WJ
    Br J Dermatol; 1991 Feb; 124(2):212-3. PubMed ID: 2004013
    [No Abstract]   [Full Text] [Related]  

  • 32. Alopecia areata in a patient with candidiasis-endocrinopathy syndrome: unsuccessful treatment trial with diphenylcyclopropenone.
    Böni R; Trüeb RM; Wüthrich B
    Dermatology; 1995; 191(1):68-71. PubMed ID: 8589491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of cytokine patterns in alopecia areata before and after therapeutic allergic contact dermatitis.
    Stricker RB; Goldberg B
    J Invest Dermatol; 1996 Feb; 106(2):379-80. PubMed ID: 8601746
    [No Abstract]   [Full Text] [Related]  

  • 37. Allergic contact dermatitis from 2-ethylhexyl acrylate contained in a wig-fixing adhesive tape and its 'incidental' therapeutic effect on alopecia areata.
    Torchia D; Giorgini S; Gola M; Francalanci S
    Contact Dermatitis; 2008 Mar; 58(3):170-1. PubMed ID: 18279158
    [No Abstract]   [Full Text] [Related]  

  • 38. Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
    Heffler LC; Kastman AL; Jacobsson Ekman G; Scheynius A; Fransson J
    Br J Dermatol; 2002 Aug; 147(2):222-9. PubMed ID: 12174091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of alopecia areata with diphenylcyclopropenone].
    Ochsendorf FR; Mitrou G; Milbradt R
    Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.